Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management

PHASE3CompletedINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Fibromyalgia
Interventions
DEVICE

Digital ACT

Participants in this arm receive Digital ACT as well as standard of care.

OTHER

Digital Symptom Tracker

Participants in this arm complete a digital symptom and function tracker and monitor, are provided access to digital fibromyalgia and health education, and receive standard of care.

Trial Locations (25)

10583

Site #32, Scarsdale

11235

Site #34, Brooklyn

14221

Site #12, Williamsville

18104

Site #16, Allentown

30329

Site #25, Atlanta

32801

Site #13, Orlando

33709

Site #33, St. Petersburg

39564

Site #24, Ocean Springs

45219

Site #14, Cincinnati

45419

Site #28, Dayton

58104

Site #27, Fargo

70124

Site #20, New Orleans

70433

Site #21, Covington

70769

Site #22, Prairieville

74133

Site #23, Tulsa

75070

Site #26, McKinney

78660

Site #30, Pflugerville

78726

Site #29, Austin

90602

Site #35, Whittier

91042

Site #36, Tujunga

91360

Site #38, Thousand Oaks

91722

Site #37, Covina

92056

Site #15, Oceanside

92498

Site #31, San Bernardino

02467

Site #39, Chestnut Hill

All Listed Sponsors
lead

Swing Therapeutics, Inc.

OTHER